nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—SLC22A4—glottis—head and neck cancer	0.0534	0.118	CbGeAlD
L-Carnitine—CROT—Vinorelbine—Vinblastine—head and neck cancer	0.0282	1	CbGdCrCtD
L-Carnitine—CROT—hair follicle—head and neck cancer	0.0254	0.056	CbGeAlD
L-Carnitine—CES1—larynx—head and neck cancer	0.0248	0.0547	CbGeAlD
L-Carnitine—CRAT—hair follicle—head and neck cancer	0.0214	0.0473	CbGeAlD
L-Carnitine—SLC22A4—larynx—head and neck cancer	0.0189	0.0417	CbGeAlD
L-Carnitine—SLC25A29—neck—head and neck cancer	0.0186	0.041	CbGeAlD
L-Carnitine—MPO—saliva—head and neck cancer	0.017	0.0374	CbGeAlD
L-Carnitine—CES1—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.0135	0.0445	CbGpPWpGaD
L-Carnitine—SLC25A20—parotid gland—head and neck cancer	0.0121	0.0266	CbGeAlD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.0117	0.0386	CbGpPWpGaD
L-Carnitine—CRAT—parotid gland—head and neck cancer	0.0117	0.0258	CbGeAlD
L-Carnitine—SLC25A20—saliva-secreting gland—head and neck cancer	0.0116	0.0255	CbGeAlD
L-Carnitine—CRAT—saliva-secreting gland—head and neck cancer	0.0112	0.0247	CbGeAlD
L-Carnitine—SLC25A20—connective tissue—head and neck cancer	0.0106	0.0234	CbGeAlD
L-Carnitine—XDH—Purine catabolism—GPX1—head and neck cancer	0.0102	0.0337	CbGpPWpGaD
L-Carnitine—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00982	0.0457	CcSEcCtD
L-Carnitine—CPT2—parotid gland—head and neck cancer	0.00901	0.0199	CbGeAlD
L-Carnitine—CES1—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00898	0.0296	CbGpPWpGaD
L-Carnitine—SLC25A20—trachea—head and neck cancer	0.00892	0.0197	CbGeAlD
L-Carnitine—SLC25A29—thyroid gland—head and neck cancer	0.00885	0.0195	CbGeAlD
L-Carnitine—CRAT—trachea—head and neck cancer	0.00866	0.0191	CbGeAlD
L-Carnitine—CPT2—saliva-secreting gland—head and neck cancer	0.00863	0.019	CbGeAlD
L-Carnitine—CPT1A—connective tissue—head and neck cancer	0.00836	0.0184	CbGeAlD
L-Carnitine—CROT—thyroid gland—head and neck cancer	0.00811	0.0179	CbGeAlD
L-Carnitine—CPT2—connective tissue—head and neck cancer	0.00793	0.0175	CbGeAlD
L-Carnitine—SLC25A29—head—head and neck cancer	0.00785	0.0173	CbGeAlD
L-Carnitine—CPT1A—AMPK Signaling—CCNA1—head and neck cancer	0.00721	0.0237	CbGpPWpGaD
L-Carnitine—CROT—head—head and neck cancer	0.0072	0.0159	CbGeAlD
L-Carnitine—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.00707	0.0329	CcSEcCtD
L-Carnitine—SLC25A20—thyroid gland—head and neck cancer	0.00706	0.0156	CbGeAlD
L-Carnitine—CRAT—thyroid gland—head and neck cancer	0.00685	0.0151	CbGeAlD
L-Carnitine—CES1—neck—head and neck cancer	0.00657	0.0145	CbGeAlD
L-Carnitine—CES1—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00639	0.021	CbGpPWpGaD
L-Carnitine—CES1—E2F transcription factor network—CEBPA—head and neck cancer	0.00638	0.021	CbGpPWpGaD
L-Carnitine—SLC25A20—head—head and neck cancer	0.00626	0.0138	CbGeAlD
L-Carnitine—CRAT—head—head and neck cancer	0.00608	0.0134	CbGeAlD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00602	0.0198	CbGpPWpGaD
L-Carnitine—CPT2—PPARA activates gene expression—YAP1—head and neck cancer	0.00576	0.019	CbGpPWpGaD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.00563	0.0185	CbGpPWpGaD
L-Carnitine—CPT1A—thyroid gland—head and neck cancer	0.00555	0.0122	CbGeAlD
L-Carnitine—CPT2—PPAR Alpha Pathway—CCND1—head and neck cancer	0.00552	0.0182	CbGpPWpGaD
L-Carnitine—SLC25A29—lymph node—head and neck cancer	0.0055	0.0121	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—CEBPA—head and neck cancer	0.0053	0.0175	CbGpPWpGaD
L-Carnitine—CPT2—thyroid gland—head and neck cancer	0.00527	0.0116	CbGeAlD
L-Carnitine—CES1—E2F transcription factor network—XRCC1—head and neck cancer	0.0052	0.0171	CbGpPWpGaD
L-Carnitine—CES1—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.00512	0.0168	CbGpPWpGaD
L-Carnitine—CROT—lymph node—head and neck cancer	0.00504	0.0111	CbGeAlD
L-Carnitine—SLC22A4—neck—head and neck cancer	0.00501	0.0111	CbGeAlD
L-Carnitine—CPT1A—head—head and neck cancer	0.00492	0.0109	CbGeAlD
L-Carnitine—CES1—connective tissue—head and neck cancer	0.00471	0.0104	CbGeAlD
L-Carnitine—CPT2—head—head and neck cancer	0.00467	0.0103	CbGeAlD
L-Carnitine—MPO—C-MYB transcription factor network—CCNA1—head and neck cancer	0.00467	0.0154	CbGpPWpGaD
L-Carnitine—XDH—Oxidative Stress—SOD2—head and neck cancer	0.00445	0.0147	CbGpPWpGaD
L-Carnitine—SLC25A20—lymph node—head and neck cancer	0.00438	0.00967	CbGeAlD
L-Carnitine—CRAT—lymph node—head and neck cancer	0.00425	0.00938	CbGeAlD
L-Carnitine—XDH—Oxidative Stress—GPX1—head and neck cancer	0.00425	0.014	CbGpPWpGaD
L-Carnitine—XDH—Oxidative Stress—CYP1A1—head and neck cancer	0.0042	0.0138	CbGpPWpGaD
L-Carnitine—CPT1A—PPARA activates gene expression—YAP1—head and neck cancer	0.00399	0.0131	CbGpPWpGaD
L-Carnitine—XDH—Purine metabolism—GPX1—head and neck cancer	0.00394	0.013	CbGpPWpGaD
L-Carnitine—MPO—connective tissue—head and neck cancer	0.00393	0.00867	CbGeAlD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—YAP1—head and neck cancer	0.0039	0.0129	CbGpPWpGaD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00388	0.0128	CbGpPWpGaD
L-Carnitine—CPT1A—PPAR Alpha Pathway—CCND1—head and neck cancer	0.00382	0.0126	CbGpPWpGaD
L-Carnitine—MPO—epithelium—head and neck cancer	0.00373	0.00824	CbGeAlD
L-Carnitine—XDH—Nucleotide metabolism—DPYD—head and neck cancer	0.00367	0.0121	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—UROD—head and neck cancer	0.00364	0.012	CbGpPWpGaD
L-Carnitine—Depression—Vinblastine—head and neck cancer	0.00353	0.0165	CcSEcCtD
L-Carnitine—CPT1A—lymph node—head and neck cancer	0.00345	0.0076	CbGeAlD
L-Carnitine—CES1—lymphoid tissue—head and neck cancer	0.00344	0.0076	CbGeAlD
L-Carnitine—SLC25A20—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.00339	0.0112	CbGpPWpGaD
L-Carnitine—MPO—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.00333	0.011	CbGpPWpGaD
L-Carnitine—Weight increased—Hydroxyurea—head and neck cancer	0.0033	0.0154	CcSEcCtD
L-Carnitine—CPT2—lymph node—head and neck cancer	0.00327	0.00722	CbGeAlD
L-Carnitine—CPT2—PPARA activates gene expression—CYP1A1—head and neck cancer	0.00324	0.0107	CbGpPWpGaD
L-Carnitine—Haemoglobin—Vinblastine—head and neck cancer	0.00319	0.0149	CcSEcCtD
L-Carnitine—Haemorrhage—Vinblastine—head and neck cancer	0.00318	0.0148	CcSEcCtD
L-Carnitine—CPT2—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.00317	0.0104	CbGpPWpGaD
L-Carnitine—Pharyngitis—Vinblastine—head and neck cancer	0.00315	0.0147	CcSEcCtD
L-Carnitine—CES1—thyroid gland—head and neck cancer	0.00313	0.0069	CbGeAlD
L-Carnitine—SLC25A20—Metabolism—UROD—head and neck cancer	0.00309	0.0102	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—UROD—head and neck cancer	0.00309	0.0102	CbGpPWpGaD
L-Carnitine—SLC22A4—trachea—head and neck cancer	0.00302	0.00665	CbGeAlD
L-Carnitine—Injection site reaction—Docetaxel—head and neck cancer	0.00298	0.0139	CcSEcCtD
L-Carnitine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00291	0.0136	CcSEcCtD
L-Carnitine—Haemorrhage—Hydroxyurea—head and neck cancer	0.0029	0.0135	CcSEcCtD
L-Carnitine—MPO—lymphoid tissue—head and neck cancer	0.00288	0.00634	CbGeAlD
L-Carnitine—SLC22A16—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00283	0.00931	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00282	0.00929	CbGpPWpGaD
L-Carnitine—CES1—head—head and neck cancer	0.00278	0.00612	CbGeAlD
L-Carnitine—CES1—E2F transcription factor network—TYMS—head and neck cancer	0.00271	0.00893	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—SOD2—head and neck cancer	0.00271	0.00893	CbGpPWpGaD
L-Carnitine—SLC22A5—parotid gland—head and neck cancer	0.0027	0.00596	CbGeAlD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.00269	0.00886	CbGpPWpGaD
L-Carnitine—Muscular weakness—Fluorouracil—head and neck cancer	0.00266	0.0124	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—TGFA—head and neck cancer	0.00265	0.00872	CbGpPWpGaD
L-Carnitine—Angiopathy—Hydroxyurea—head and neck cancer	0.00263	0.0123	CcSEcCtD
L-Carnitine—SLC22A5—saliva-secreting gland—head and neck cancer	0.00259	0.0057	CbGeAlD
L-Carnitine—MPO—Folate Metabolism—GPX1—head and neck cancer	0.00259	0.00851	CbGpPWpGaD
L-Carnitine—Anaemia—Vinblastine—head and neck cancer	0.00256	0.0119	CcSEcCtD
L-Carnitine—Vertigo—Vinblastine—head and neck cancer	0.00249	0.0116	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.0024	0.0079	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.0024	0.0079	CbGpPWpGaD
L-Carnitine—Convulsion—Vinblastine—head and neck cancer	0.0024	0.0112	CcSEcCtD
L-Carnitine—Hypertension—Vinblastine—head and neck cancer	0.00239	0.0111	CcSEcCtD
L-Carnitine—SLC22A4—thyroid gland—head and neck cancer	0.00239	0.00526	CbGeAlD
L-Carnitine—Anaemia—Hydroxyurea—head and neck cancer	0.00233	0.0109	CcSEcCtD
L-Carnitine—MPO—head—head and neck cancer	0.00232	0.00511	CbGeAlD
L-Carnitine—Atrial fibrillation—Docetaxel—head and neck cancer	0.0023	0.0107	CcSEcCtD
L-Carnitine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00226	0.0105	CcSEcCtD
L-Carnitine—CPT1A—PPARA activates gene expression—CYP1A1—head and neck cancer	0.00224	0.00739	CbGpPWpGaD
L-Carnitine—MPO—IL23-mediated signaling events—IL2—head and neck cancer	0.00224	0.00738	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—GSTM1—head and neck cancer	0.00223	0.00733	CbGpPWpGaD
L-Carnitine—CPT1A—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.0022	0.00723	CbGpPWpGaD
L-Carnitine—Convulsion—Hydroxyurea—head and neck cancer	0.00219	0.0102	CcSEcCtD
L-Carnitine—CPT2—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.00218	0.00719	CbGpPWpGaD
L-Carnitine—Sinusitis—Fluorouracil—head and neck cancer	0.00218	0.0102	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00215	0.00709	CbGpPWpGaD
L-Carnitine—Anorexia—Vinblastine—head and neck cancer	0.00215	0.01	CcSEcCtD
L-Carnitine—Haemoglobin—Fluorouracil—head and neck cancer	0.0021	0.00977	CcSEcCtD
L-Carnitine—Rhinitis—Fluorouracil—head and neck cancer	0.00209	0.00975	CcSEcCtD
L-Carnitine—XDH—Nucleotide metabolism—TYMS—head and neck cancer	0.00209	0.00688	CbGpPWpGaD
L-Carnitine—Haemorrhage—Fluorouracil—head and neck cancer	0.00209	0.00972	CcSEcCtD
L-Carnitine—Pharyngitis—Fluorouracil—head and neck cancer	0.00207	0.00965	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00205	0.00676	CbGpPWpGaD
L-Carnitine—Infection—Hydroxyurea—head and neck cancer	0.00205	0.00953	CcSEcCtD
L-Carnitine—Paraesthesia—Vinblastine—head and neck cancer	0.00203	0.00945	CcSEcCtD
L-Carnitine—SLC22A5—trachea—head and neck cancer	0.002	0.0044	CbGeAlD
L-Carnitine—CPT2—Metabolism—UROD—head and neck cancer	0.00199	0.00656	CbGpPWpGaD
L-Carnitine—XDH—Nucleotide metabolism—GPX1—head and neck cancer	0.00198	0.00651	CbGpPWpGaD
L-Carnitine—Anorexia—Hydroxyurea—head and neck cancer	0.00196	0.00915	CcSEcCtD
L-Carnitine—Decreased appetite—Vinblastine—head and neck cancer	0.00196	0.00915	CcSEcCtD
L-Carnitine—CES1—lymph node—head and neck cancer	0.00194	0.00429	CbGeAlD
L-Carnitine—Pain—Vinblastine—head and neck cancer	0.00193	0.009	CcSEcCtD
L-Carnitine—Constipation—Vinblastine—head and neck cancer	0.00193	0.009	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—STAT3—head and neck cancer	0.00189	0.00621	CbGpPWpGaD
L-Carnitine—XDH—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00188	0.0062	CbGpPWpGaD
L-Carnitine—Arrhythmia—Fluorouracil—head and neck cancer	0.00186	0.00869	CcSEcCtD
L-Carnitine—SLC22A8—head—head and neck cancer	0.00185	0.00409	CbGeAlD
L-Carnitine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00185	0.00861	CcSEcCtD
L-Carnitine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00184	0.00856	CcSEcCtD
L-Carnitine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00181	0.00845	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—GPX1—head and neck cancer	0.0018	0.00591	CbGpPWpGaD
L-Carnitine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00179	0.00834	CcSEcCtD
L-Carnitine—Abdominal pain—Vinblastine—head and neck cancer	0.00179	0.00832	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00178	0.00829	CcSEcCtD
L-Carnitine—Pain—Hydroxyurea—head and neck cancer	0.00176	0.00821	CcSEcCtD
L-Carnitine—Constipation—Hydroxyurea—head and neck cancer	0.00176	0.00821	CcSEcCtD
L-Carnitine—Weight increased—Docetaxel—head and neck cancer	0.00171	0.00798	CcSEcCtD
L-Carnitine—Weight decreased—Docetaxel—head and neck cancer	0.0017	0.00793	CcSEcCtD
L-Carnitine—CES1—Fluoropyrimidine Activity—TP53—head and neck cancer	0.0017	0.00559	CbGpPWpGaD
L-Carnitine—Anaemia—Fluorouracil—head and neck cancer	0.00168	0.00782	CcSEcCtD
L-Carnitine—Hypersensitivity—Vinblastine—head and neck cancer	0.00166	0.00775	CcSEcCtD
L-Carnitine—Renal failure—Docetaxel—head and neck cancer	0.00165	0.00768	CcSEcCtD
L-Carnitine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00163	0.00759	CcSEcCtD
L-Carnitine—MPO—lymph node—head and neck cancer	0.00162	0.00358	CbGeAlD
L-Carnitine—Asthenia—Vinblastine—head and neck cancer	0.00162	0.00755	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.0016	0.00528	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00159	0.00523	CbGpPWpGaD
L-Carnitine—SLC22A5—thyroid gland—head and neck cancer	0.00158	0.00348	CbGeAlD
L-Carnitine—Convulsion—Fluorouracil—head and neck cancer	0.00157	0.00733	CcSEcCtD
L-Carnitine—Myalgia—Fluorouracil—head and neck cancer	0.00155	0.00721	CcSEcCtD
L-Carnitine—Chest pain—Fluorouracil—head and neck cancer	0.00155	0.00721	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00155	0.00509	CbGpPWpGaD
L-Carnitine—Diarrhoea—Vinblastine—head and neck cancer	0.00155	0.0072	CcSEcCtD
L-Carnitine—CES1—NRF2 pathway—GSTM1—head and neck cancer	0.00154	0.00507	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00152	0.00707	CcSEcCtD
L-Carnitine—CPT1A—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.00151	0.00498	CbGpPWpGaD
L-Carnitine—Haemoglobin—Docetaxel—head and neck cancer	0.00151	0.00705	CcSEcCtD
L-Carnitine—CROT—Metabolism—NAT2—head and neck cancer	0.00151	0.00497	CbGpPWpGaD
L-Carnitine—Rhinitis—Docetaxel—head and neck cancer	0.00151	0.00704	CcSEcCtD
L-Carnitine—Haemorrhage—Docetaxel—head and neck cancer	0.00151	0.00702	CcSEcCtD
L-Carnitine—Pharyngitis—Docetaxel—head and neck cancer	0.00149	0.00697	CcSEcCtD
L-Carnitine—Dizziness—Vinblastine—head and neck cancer	0.00149	0.00696	CcSEcCtD
L-Carnitine—MPO—IL23-mediated signaling events—PIK3CA—head and neck cancer	0.00149	0.0049	CbGpPWpGaD
L-Carnitine—Oedema peripheral—Docetaxel—head and neck cancer	0.00148	0.00691	CcSEcCtD
L-Carnitine—SLC22A4—lymph node—head and neck cancer	0.00148	0.00327	CbGeAlD
L-Carnitine—CPT1A—Circadian rythm related genes—TYMS—head and neck cancer	0.00148	0.00487	CbGpPWpGaD
L-Carnitine—Asthenia—Hydroxyurea—head and neck cancer	0.00148	0.00689	CcSEcCtD
L-Carnitine—Infection—Fluorouracil—head and neck cancer	0.00147	0.00686	CcSEcCtD
L-Carnitine—Tachycardia—Fluorouracil—head and neck cancer	0.00145	0.00674	CcSEcCtD
L-Carnitine—Vomiting—Vinblastine—head and neck cancer	0.00144	0.00669	CcSEcCtD
L-Carnitine—Headache—Vinblastine—head and neck cancer	0.00141	0.00659	CcSEcCtD
L-Carnitine—Anorexia—Fluorouracil—head and neck cancer	0.00141	0.00658	CcSEcCtD
L-Carnitine—MPO—Folate Metabolism—IL2—head and neck cancer	0.00141	0.00465	CbGpPWpGaD
L-Carnitine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00141	0.00657	CcSEcCtD
L-Carnitine—Eye disorder—Docetaxel—head and neck cancer	0.00141	0.00656	CcSEcCtD
L-Carnitine—CPT1A—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.0014	0.0046	CbGpPWpGaD
L-Carnitine—Hypotension—Fluorouracil—head and neck cancer	0.00139	0.00646	CcSEcCtD
L-Carnitine—CPT1A—Metabolism—UROD—head and neck cancer	0.00138	0.00455	CbGpPWpGaD
L-Carnitine—Angiopathy—Docetaxel—head and neck cancer	0.00137	0.00637	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00136	0.00449	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00136	0.00449	CbGpPWpGaD
L-Carnitine—Dizziness—Hydroxyurea—head and neck cancer	0.00136	0.00635	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00135	0.00629	CcSEcCtD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00135	0.00444	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00135	0.00444	CbGpPWpGaD
L-Carnitine—Arrhythmia—Docetaxel—head and neck cancer	0.00135	0.00627	CcSEcCtD
L-Carnitine—Nausea—Vinblastine—head and neck cancer	0.00134	0.00625	CcSEcCtD
L-Carnitine—Insomnia—Fluorouracil—head and neck cancer	0.00134	0.00625	CcSEcCtD
L-Carnitine—Paraesthesia—Fluorouracil—head and neck cancer	0.00133	0.0062	CcSEcCtD
L-Carnitine—CROT—Metabolism—DPYD—head and neck cancer	0.00132	0.00436	CbGpPWpGaD
L-Carnitine—Dyspnoea—Fluorouracil—head and neck cancer	0.00132	0.00616	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—BCL2—head and neck cancer	0.00132	0.00435	CbGpPWpGaD
L-Carnitine—Vomiting—Hydroxyurea—head and neck cancer	0.00131	0.0061	CcSEcCtD
L-Carnitine—Dyspepsia—Fluorouracil—head and neck cancer	0.0013	0.00608	CcSEcCtD
L-Carnitine—Rash—Hydroxyurea—head and neck cancer	0.0013	0.00605	CcSEcCtD
L-Carnitine—Dermatitis—Hydroxyurea—head and neck cancer	0.0013	0.00605	CcSEcCtD
L-Carnitine—Headache—Hydroxyurea—head and neck cancer	0.00129	0.00601	CcSEcCtD
L-Carnitine—Decreased appetite—Fluorouracil—head and neck cancer	0.00129	0.00601	CcSEcCtD
L-Carnitine—Dysgeusia—Docetaxel—head and neck cancer	0.00128	0.00598	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—NAT2—head and neck cancer	0.00128	0.00423	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—NAT2—head and neck cancer	0.00128	0.00423	CbGpPWpGaD
L-Carnitine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00128	0.00596	CcSEcCtD
L-Carnitine—Back pain—Docetaxel—head and neck cancer	0.00127	0.00591	CcSEcCtD
L-Carnitine—Pain—Fluorouracil—head and neck cancer	0.00127	0.00591	CcSEcCtD
L-Carnitine—Muscle spasms—Docetaxel—head and neck cancer	0.00126	0.00587	CcSEcCtD
L-Carnitine—CROT—Metabolism—YAP1—head and neck cancer	0.00126	0.00414	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—PTGS2—head and neck cancer	0.00126	0.00413	CbGpPWpGaD
L-Carnitine—Nausea—Hydroxyurea—head and neck cancer	0.00122	0.0057	CcSEcCtD
L-Carnitine—Anaemia—Docetaxel—head and neck cancer	0.00121	0.00565	CcSEcCtD
L-Carnitine—MPO—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00121	0.00398	CbGpPWpGaD
L-Carnitine—CPT1A—AMPK Signaling—PIK3CA—head and neck cancer	0.00119	0.00393	CbGpPWpGaD
L-Carnitine—Body temperature increased—Fluorouracil—head and neck cancer	0.00117	0.00546	CcSEcCtD
L-Carnitine—Palpitations—Docetaxel—head and neck cancer	0.00116	0.0054	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—TP53—head and neck cancer	0.00115	0.0038	CbGpPWpGaD
L-Carnitine—Cough—Docetaxel—head and neck cancer	0.00114	0.00533	CcSEcCtD
L-Carnitine—Convulsion—Docetaxel—head and neck cancer	0.00114	0.00529	CcSEcCtD
L-Carnitine—MPO—C-MYB transcription factor network—CCND1—head and neck cancer	0.00113	0.00373	CbGpPWpGaD
L-Carnitine—Hypertension—Docetaxel—head and neck cancer	0.00113	0.00527	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—DPYD—head and neck cancer	0.00113	0.00371	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—DPYD—head and neck cancer	0.00113	0.00371	CbGpPWpGaD
L-Carnitine—Chest pain—Docetaxel—head and neck cancer	0.00112	0.0052	CcSEcCtD
L-Carnitine—Myalgia—Docetaxel—head and neck cancer	0.00112	0.0052	CcSEcCtD
L-Carnitine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00109	0.00509	CcSEcCtD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00107	0.00353	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—YAP1—head and neck cancer	0.00107	0.00352	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—YAP1—head and neck cancer	0.00107	0.00352	CbGpPWpGaD
L-Carnitine—Infection—Docetaxel—head and neck cancer	0.00106	0.00495	CcSEcCtD
L-Carnitine—XDH—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00106	0.00348	CbGpPWpGaD
L-Carnitine—Pruritus—Fluorouracil—head and neck cancer	0.00105	0.00489	CcSEcCtD
L-Carnitine—SLC22A4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00105	0.00344	CbGpPWpGaD
L-Carnitine—Tachycardia—Docetaxel—head and neck cancer	0.00104	0.00487	CcSEcCtD
L-Carnitine—Anorexia—Docetaxel—head and neck cancer	0.00102	0.00475	CcSEcCtD
L-Carnitine—Diarrhoea—Fluorouracil—head and neck cancer	0.00101	0.00473	CcSEcCtD
L-Carnitine—Hypotension—Docetaxel—head and neck cancer	0.001	0.00466	CcSEcCtD
L-Carnitine—SLC22A5—lymph node—head and neck cancer	0.000981	0.00216	CbGeAlD
L-Carnitine—Dizziness—Fluorouracil—head and neck cancer	0.00098	0.00457	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000975	0.00454	CcSEcCtD
L-Carnitine—CPT1A—AMPK Signaling—AKT1—head and neck cancer	0.000974	0.00321	CbGpPWpGaD
L-Carnitine—Insomnia—Docetaxel—head and neck cancer	0.000968	0.00451	CcSEcCtD
L-Carnitine—Paraesthesia—Docetaxel—head and neck cancer	0.000961	0.00448	CcSEcCtD
L-Carnitine—Dyspnoea—Docetaxel—head and neck cancer	0.000954	0.00445	CcSEcCtD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000944	0.00311	CbGpPWpGaD
L-Carnitine—Vomiting—Fluorouracil—head and neck cancer	0.000943	0.00439	CcSEcCtD
L-Carnitine—Dyspepsia—Docetaxel—head and neck cancer	0.000942	0.00439	CcSEcCtD
L-Carnitine—Rash—Fluorouracil—head and neck cancer	0.000935	0.00436	CcSEcCtD
L-Carnitine—Dermatitis—Fluorouracil—head and neck cancer	0.000934	0.00435	CcSEcCtD
L-Carnitine—Decreased appetite—Docetaxel—head and neck cancer	0.00093	0.00433	CcSEcCtD
L-Carnitine—Headache—Fluorouracil—head and neck cancer	0.000929	0.00433	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000924	0.0043	CcSEcCtD
L-Carnitine—Pain—Docetaxel—head and neck cancer	0.000915	0.00426	CcSEcCtD
L-Carnitine—Constipation—Docetaxel—head and neck cancer	0.000915	0.00426	CcSEcCtD
L-Carnitine—XDH—Metabolism—UROD—head and neck cancer	0.000915	0.00301	CbGpPWpGaD
L-Carnitine—MPO—Folate Metabolism—TP53—head and neck cancer	0.000906	0.00298	CbGpPWpGaD
L-Carnitine—Nausea—Fluorouracil—head and neck cancer	0.000881	0.0041	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000879	0.00289	CbGpPWpGaD
L-Carnitine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000875	0.00408	CcSEcCtD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00087	0.00286	CbGpPWpGaD
L-Carnitine—Abdominal pain—Docetaxel—head and neck cancer	0.000846	0.00394	CcSEcCtD
L-Carnitine—Body temperature increased—Docetaxel—head and neck cancer	0.000846	0.00394	CcSEcCtD
L-Carnitine—CPT2—Metabolism—NAT2—head and neck cancer	0.000827	0.00272	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000823	0.00271	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000803	0.00264	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000803	0.00264	CbGpPWpGaD
L-Carnitine—CPT1A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000795	0.00262	CbGpPWpGaD
L-Carnitine—Hypersensitivity—Docetaxel—head and neck cancer	0.000788	0.00367	CcSEcCtD
L-Carnitine—SLC22A5—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000786	0.00259	CbGpPWpGaD
L-Carnitine—Asthenia—Docetaxel—head and neck cancer	0.000768	0.00358	CcSEcCtD
L-Carnitine—Pruritus—Docetaxel—head and neck cancer	0.000757	0.00353	CcSEcCtD
L-Carnitine—CROT—Metabolism—TYMS—head and neck cancer	0.000754	0.00248	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GSTM1—head and neck cancer	0.000746	0.00246	CbGpPWpGaD
L-Carnitine—Diarrhoea—Docetaxel—head and neck cancer	0.000732	0.00341	CcSEcCtD
L-Carnitine—CPT2—Metabolism—DPYD—head and neck cancer	0.000725	0.00239	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—PTEN—head and neck cancer	0.000719	0.00237	CbGpPWpGaD
L-Carnitine—MPO—C-MYB transcription factor network—HRAS—head and neck cancer	0.000715	0.00235	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—GPX1—head and neck cancer	0.000714	0.00235	CbGpPWpGaD
L-Carnitine—SLC22A8—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000711	0.00234	CbGpPWpGaD
L-Carnitine—Dizziness—Docetaxel—head and neck cancer	0.000708	0.0033	CcSEcCtD
L-Carnitine—CROT—Metabolism—CYP1A1—head and neck cancer	0.000707	0.00233	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.0007	0.0023	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.0007	0.0023	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—YAP1—head and neck cancer	0.000688	0.00227	CbGpPWpGaD
L-Carnitine—Vomiting—Docetaxel—head and neck cancer	0.00068	0.00317	CcSEcCtD
L-Carnitine—Rash—Docetaxel—head and neck cancer	0.000675	0.00314	CcSEcCtD
L-Carnitine—Dermatitis—Docetaxel—head and neck cancer	0.000674	0.00314	CcSEcCtD
L-Carnitine—Headache—Docetaxel—head and neck cancer	0.00067	0.00312	CcSEcCtD
L-Carnitine—SLC25A20—Metabolism—TYMS—head and neck cancer	0.000641	0.00211	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—TYMS—head and neck cancer	0.000641	0.00211	CbGpPWpGaD
L-Carnitine—Nausea—Docetaxel—head and neck cancer	0.000636	0.00296	CcSEcCtD
L-Carnitine—CRAT—Metabolism—GSTM1—head and neck cancer	0.000634	0.00209	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GSTM1—head and neck cancer	0.000634	0.00209	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000609	0.00201	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—GPX1—head and neck cancer	0.000607	0.002	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—GPX1—head and neck cancer	0.000607	0.002	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000603	0.00198	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—CYP1A1—head and neck cancer	0.000601	0.00198	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—CYP1A1—head and neck cancer	0.000601	0.00198	CbGpPWpGaD
L-Carnitine—CROT—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000581	0.00191	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—NAT2—head and neck cancer	0.000573	0.00189	CbGpPWpGaD
L-Carnitine—SLCO1B1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00054	0.00178	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000517	0.0017	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—DPYD—head and neck cancer	0.000503	0.00166	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000494	0.00163	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000494	0.00163	CbGpPWpGaD
L-Carnitine—CPT1A—Circadian rythm related genes—TP53—head and neck cancer	0.000491	0.00162	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—UROD—head and neck cancer	0.000481	0.00159	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—YAP1—head and neck cancer	0.000477	0.00157	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000451	0.00149	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTGS2—head and neck cancer	0.00042	0.00138	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—TYMS—head and neck cancer	0.000413	0.00136	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GSTM1—head and neck cancer	0.000409	0.00135	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—GPX1—head and neck cancer	0.000391	0.00129	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—CYP1A1—head and neck cancer	0.000387	0.00128	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—NAT2—head and neck cancer	0.00038	0.00125	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000374	0.00123	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PTEN—head and neck cancer	0.000367	0.00121	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000359	0.00118	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTGS2—head and neck cancer	0.000357	0.00118	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTGS2—head and neck cancer	0.000357	0.00118	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—DPYD—head and neck cancer	0.000333	0.0011	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000318	0.00105	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—YAP1—head and neck cancer	0.000316	0.00104	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000313	0.00103	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PTEN—head and neck cancer	0.000312	0.00103	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PTEN—head and neck cancer	0.000312	0.00103	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—TYMS—head and neck cancer	0.000287	0.000943	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GSTM1—head and neck cancer	0.000283	0.000932	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—GPX1—head and neck cancer	0.000271	0.000893	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—CYP1A1—head and neck cancer	0.000268	0.000884	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—PIK3CA—head and neck cancer	0.000259	0.000852	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTGS2—head and neck cancer	0.00023	0.000758	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000221	0.000726	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—PIK3CA—head and neck cancer	0.00022	0.000724	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—PIK3CA—head and neck cancer	0.00022	0.000724	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000212	0.000699	CbGpPWpGaD
L-Carnitine—CROT—Metabolism—AKT1—head and neck cancer	0.000211	0.000696	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00021	0.000692	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PTEN—head and neck cancer	0.000201	0.000661	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—NAT2—head and neck cancer	0.0002	0.000658	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—TYMS—head and neck cancer	0.00019	0.000625	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GSTM1—head and neck cancer	0.000188	0.000618	CbGpPWpGaD
L-Carnitine—CRAT—Metabolism—AKT1—head and neck cancer	0.00018	0.000592	CbGpPWpGaD
L-Carnitine—SLC25A20—Metabolism—AKT1—head and neck cancer	0.00018	0.000592	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—GPX1—head and neck cancer	0.00018	0.000592	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—CYP1A1—head and neck cancer	0.000178	0.000586	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—DPYD—head and neck cancer	0.000175	0.000577	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—YAP1—head and neck cancer	0.000166	0.000548	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTGS2—head and neck cancer	0.00016	0.000526	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—PIK3CA—head and neck cancer	0.000142	0.000467	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PTEN—head and neck cancer	0.000139	0.000458	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000125	0.000412	CbGpPWpGaD
L-Carnitine—CPT2—Metabolism—AKT1—head and neck cancer	0.000116	0.000381	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000109	0.000359	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTGS2—head and neck cancer	0.000106	0.000348	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—TYMS—head and neck cancer	9.99e-05	0.000329	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GSTM1—head and neck cancer	9.87e-05	0.000325	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—PIK3CA—head and neck cancer	9.82e-05	0.000323	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—GPX1—head and neck cancer	9.46e-05	0.000311	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	9.36e-05	0.000308	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PTEN—head and neck cancer	9.22e-05	0.000304	CbGpPWpGaD
L-Carnitine—CPT1A—Metabolism—AKT1—head and neck cancer	8.02e-05	0.000264	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.69e-05	0.000253	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—PIK3CA—head and neck cancer	6.51e-05	0.000214	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTGS2—head and neck cancer	5.57e-05	0.000183	CbGpPWpGaD
L-Carnitine—XDH—Metabolism—AKT1—head and neck cancer	5.32e-05	0.000175	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PTEN—head and neck cancer	4.85e-05	0.00016	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	3.42e-05	0.000113	CbGpPWpGaD
L-Carnitine—SLCO1B1—Metabolism—AKT1—head and neck cancer	2.8e-05	9.21e-05	CbGpPWpGaD
